allogenic mesenchymal stem cell therapy (TiGenix)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameallogenic mesenchymal stem cell therapy (TiGenix)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionBone synthesis stimulants

TargetsUpdating

Therapy Area/IndicationsOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTigenix Nv

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTigenix Nv

Active IndicationsN/A

Inactive IndicationsOsteoarthritis

ATC CodeN/A